Michael Nanna, MD

Advanced Training Program
Start Year
2020

Education and Training

Medical School
State University of NY at Stony Brook

Residency
Yale University

Cardiovascular Disease Fellowship
Duke University

Advanced Training in Cardiology Fellowship
Duke University


Fellow Perspective

Tell us briefly about your background before fellowship?
I grew up in and around New York and did my residency/chief residency at Yale. I was involved in clinical research as a resident but had no dedicated research training prior to fellowship.

What are your career plans in cardiology?
I plan to pursue a career in academic cardiology as an interventional cardiologist while conducting clinical research in the prevention, diagnosis and treatment of coronary artery disease.

Why did you choose Duke for your fellowship training?
I thought it provided, hands down, the most well-rounded training of any program in the country. I did not find any other program that combined both intense clinical and procedural training with superior training in research. That’s exactly what you get when you train at Duke. 

What advice might you offer residents looking at fellowship programs?
Keep an open mind. I had no reason to move down South before interviewing at Duke, but I came away from my interview without any doubt that this was the best program. Make sure to talk to graduates from your residency program for guidance.

From your experience in fellowship, what have you learned about training at Duke?
Duke is a place of unlimited opportunities. If you’re willing to work hard here, there is nothing you can’t accomplish as a fellow. Also, the rec softball team (“Number Needed to Harm”) is the unquestioned heart and soul of the division.

How is your life in the Triangle area outside of work?
Fantastic. The Triangle is such a unique and vibrant place to live. My fiancé and I are “Yankees” so we had our reservations before moving here but now I can’t imagine leaving. Perfect weather, great restaurants, amazing sports, beach & mountains close by, what’s not to love?

Publications

Nanna, Michael G., Eric D. Peterson, Daniel Wojdyla, and Ann Marie Navar. “The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults.” J Gen Intern Med 35, no. 6 (June 2020): 1701–8. https://doi.org/10.1007/s11606-019-05361-4.

PMID
31667745
Full Text

Nanna, Michael G., Eric D. Peterson, Angie Wu, Tina Harding, Anthony N. Galanos, Lisa Wruck, and Karen P. Alexander. “Age, knowledge, preferences, and risk tolerance for invasive cardiac care.” Am Heart J 219 (January 2020): 99–108. https://doi.org/10.1016/j.ahj.2019.09.008.

PMID
31733450
Full Text

Nanna, Michael G., Ann Marie Navar, Tracy Y. Wang, Shuang Li, Salim S. Virani, Zhuokai Li, Jennifer G. Robinson, et al. “Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.” Am Heart J 214 (August 2019): 113–24. https://doi.org/10.1016/j.ahj.2019.05.009.

PMID
31202098
Full Text

Nanna, Michael G., Ann Marie Navar, Pearl Zakroysky, Qun Xiang, Anne C. Goldberg, Jennifer Robinson, Veronique L. Roger, et al. “Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.” Jama Cardiol 3, no. 8 (August 1, 2018): 739–48. https://doi.org/10.1001/jamacardio.2018.1511.

PMID
29898219
Full Text

Nanna, Michael G., Ann Marie Navar, Tracy Y. Wang, Xiaojuan Mi, Salim S. Virani, Michael J. Louie, L Veronica Lee, et al. “75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.” J Am Heart Assoc 7, no. 10 (May 8, 2018). https://doi.org/10.1161/JAHA.118.008546.

PMID
29739801
Full Text

Hammond, Christa A., Natalie J. Blades, Sarwat I. Chaudhry, John A. Dodson, W. T. Longstreth, Susan R. Heckbert, Bruce M. Psaty, et al. “Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study).” Circulation. Heart Failure 11, no. 3 (March 2018): e004476. https://doi.org/10.1161/circheartfailure.117.004476.

PMID
29523517
Full Text

Navar, Ann Marie, Eric D. Peterson, Shuang Li, Jennifer G. Robinson, Veronique L. Roger, Anne C. Goldberg, Salim Virani, et al. “Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.” Circ Cardiovasc Qual Outcomes 11, no. 3 (March 2018): e004249. https://doi.org/10.1161/CIRCOUTCOMES.117.004249.

PMID
29545393
Full Text

Bazemore, Taylor C., Michael G. Nanna, and Sunil V. Rao. “Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina.” J Thromb Thrombolysis 44, no. 3 (October 2017): 303–15. https://doi.org/10.1007/s11239-017-1529-6.

PMID
28730406
Full Text

Nanna, Michael G., Paulina Gomes, Roland F. Njoh, Charisse Ward, Robert R. Attaran, and Carlos Mena. “Carotid artery stenting versus carotid endarterectomy.” Postgraduate Medical Journal 92, no. 1091 (September 2016): 532–39. https://doi.org/10.1136/postgradmedj-2015-133689.

Full Text

Feder, Shelli L., Dena Schulman-Green, John A. Dodson, Mary Geda, Kathleen Williams, Michael G. Nanna, Heather G. Allore, et al. “Risk Stratification in Older Patients With Acute Myocardial Infarction.” Journal of Aging and Health 28, no. 3 (April 2016): 387–402. https://doi.org/10.1177/0898264315591005.

Full Text

Pages